Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1318 Articles

Alex Sirois | Jul 13, 2026 at 12:22 PM EDT

JNJ Vs. KO: Which Dividend Stock Is The Better Buy?

Both Johnson and Johnson and Coca-Cola just beat earnings and both are pulling in capital fleeing tech, but only one…

Drew Wood | Jul 13, 2026 at 9:54 AM EDT

Think You’ll Live on $80,000 a Year? Here’s What Actually Lands in Your Checking Account

An $80,000 salary is not the same as $80,000 of spendable income. Federal withholding, FICA taxes, state income taxes where…

Joel South | Jul 13, 2026 at 8:30 AM EDT

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into…

Drew Wood | Jul 13, 2026 at 6:45 AM EDT

This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School

A legal career can eventually deliver a six-figure income, but the path is rarely passive. The median annual wage for…

Drew Wood | Jul 13, 2026 at 5:00 AM EDT

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The math on replacing $60,000 of annual income looks simple until you ask a different question. At a 3.5% yield,…

Drew Wood | Jul 12, 2026 at 3:09 PM EDT

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year

Ten years ago, a buyer of Lowe’s (NYSE:LOW | LOW Price Prediction) could pick up shares near $66 and collect…

Drew Wood | Jul 12, 2026 at 11:24 AM EDT

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

Two retirees can both pull $100,000 from $2 million income portfolios and still land in very different places after tax.…

Drew Wood | Jul 11, 2026 at 12:42 PM EDT

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

A 10% dividend feels like a win because it solves the income problem with less capital. The arithmetic is seductive:…

Drew Wood | Jul 11, 2026 at 11:30 AM EDT

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

A stock screener sorted by current yield misses one of the most powerful income stories in the market. Microsoft (NASDAQ:…

Drew Wood | Jul 11, 2026 at 10:15 AM EDT

The Retirement Budget Most People Build Is Backward

Most retirement budgets start with the wrong question. The instinct is to ask, “What yield do I need so the…

Ian Cooper | Jul 11, 2026 at 8:19 AM EDT

Volatility Isn’t the Risk You Should Fear — These Are

Most investors panic when stocks turn red, but the losses that actually destroy wealth rarely show up on a bad…

Drew Wood | Jul 10, 2026 at 3:00 PM EDT

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

Replacing $7,500 a month with dividends is a math problem before it is anything else. The number you need to…

Drew Wood | Jul 10, 2026 at 12:30 PM EDT

A Dividend Portfolio That Pays For Your Pets

Rescuing a dog or cat can easily turn into a 10- to 20-year financial commitment. Medium-sized dogs often live around…

David Moadel | Jul 10, 2026 at 12:04 PM EDT

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Moderna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors…

Vandita Jadeja | Jul 10, 2026 at 11:30 AM EDT

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JNJ and AbbVie both beat revenue expectations in Q1 2026, yet their strategies could not look more different, and which…

1 2 3 4 5 … 88

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

JNJ Vs. KO: Which Dividend Stock Is The Better Buy?

Think You’ll Live on $80,000 a Year? Here’s What Actually Lands in Your Checking Account

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

The Retirement Budget Most People Build Is Backward

Volatility Isn’t the Risk You Should Fear — These Are

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

A Dividend Portfolio That Pays For Your Pets

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

JNJ Vs. KO: Which Dividend Stock Is The Better Buy?

Think You’ll Live on $80,000 a Year? Here’s What Actually Lands in Your Checking Account

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

This Portfolio Lets You Earn More Than a Lawyer… Without Going to Law School

The Dividend Growth Roadmap That Turns $60,000 a Year Into More Than $125,000

The Dividend Growth Approach That Builds Bigger Paychecks Every Single Year

Your Dividend Yield Isn’t Your Income: What You Really Keep After Taxes

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Why Today’s Small Dividend Could Become Tomorrow’s Retirement Engine

The Retirement Budget Most People Build Is Backward

Volatility Isn’t the Risk You Should Fear — These Are

Three Dividend Strategies That Can Produce $7,500 a Month and Which One Comes Out Ahead

A Dividend Portfolio That Pays For Your Pets

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

Featured Reads

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings